Table 1.
Descriptive statistics on study subjects and blood pressure measurements.
| Values | Total (n = 98,577) | Hypertension (n = 31,267) | Normotension (n = 67,310) |
|---|---|---|---|
| Age, years | 55.5 ± 14.9 | 61.8 ± 14.1 | 52.6 ± 14.4 |
| Male sex, n (%) | 49,452 (50.2) | 16,866 (53.9) | 32,586 (48.4) |
| Body mass index, kg/m2* | 23.83 ± 0.49 | 25.16 ± 0.41 | 23.83 ± 0.49 |
| Blood pressure measurements | |||
| Systolic blood pressure, mmHg | 122.8 ± 16.3 | 127.1 ± 17.8 | 120.8 ± 15.1 |
| Diastolic blood pressure, mmHg | 74.1 ± 11.1 | 75.6 ± 11.8 | 73.4 ± 10.6 |
| Pulse rate, per minute | 79.3 ± 13.4 | 78.3 ± 13.8 | 79.8 ± 13.2 |
| Comorbidities | |||
| Diabetes mellitus, n (%) | 7553 (7.7) | 5732 (18.3) | 1821 (2.7) |
| Dyslipidemia, n (%) | 10,288 (10.4) | 6584 (21.1) | 3704 (5.5) |
| Medication, n (%) | |||
| Antihypertensive agents | |||
| ACEI/ARB | 13,582 (13.8) | 13,582 (43.4) | — |
| Calcium channel blockers | 17,505 (17.8) | 17,505 (56.0) | — |
| β-blockers | 17,090 (17.3) | 17,090 (54.7) | — |
| Diuretics | 7565 (7.7) | 7565 (24.2) | — |
| Statin | 17,813 (18.1) | 13,632 (43.6) | 4181 (6.2) |
Data are reported as numbers and percentages for categorical variables and mean ± standard deviation (SD) for continuous ones. *Body mass index was only available in 59,215 subjects (61.1%).
ACEI denotes angiotensin-converting-enzyme inhibitor; ARB, angiotensin II receptor blockers.